Value articulation EPI-Q focuses on health economics and outcomes research to demonstrate clinical and economic value of therapies, suggesting potential sales opportunities around value-based pricing, market access support, and reimbursement strategies for biopharma and medical device clients.

Lifecycle evidence With a track record spanning over 27 years in generating real-world evidence across product lifecycles, there is a sales opening to offer ongoing evidence generation, publication, and communications services to sustain product value post-launch.

Global partnerships An international network across payer, provider, policy, and academic communities enables EPI-Q to tailor global strategies, presenting upsell opportunities for multinational clients seeking harmonized health economic studies and PLATFORM-wide market access support.

Small expert team Despite a lean headcount, EPI-Q arrays multidisciplinary experts in clinical practice, methodology, health economics, and policy, indicating opportunities to position premium, bespoke consulting services and high-touch engagements for niche value propositions.

Digital footprint Current tech stack includes WordPress and analytics tools, indicating potential upsell to enhanced digital marketing, analytics-driven client reporting, and smarter dissemination of value evidence to payers and providers.